High-Resolution Single-Cell DNA Methylation Measurements Reveal Epigenetically Distinct Hematopoietic Stem Cell Subpopulations

Tony Hui, Qi Cao, Joanna Wegrzyn-Woltosz, Kieran O'Neill, Colin A. Hammond, David J.H.F. Knapp, Emma Laks, Michelle Moksa, Samuel Aparicio, Connie J. Eaves, Aly Karsan, Martin Hirst

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

66 Citas (Scopus)

Resumen

Increasing evidence of functional and transcriptional heterogeneity in phenotypically similar cells examined individually has prompted interest in obtaining parallel methylome data. We describe the development and application of such a protocol to index-sorted murine and human hematopoietic cells that are highly enriched in their content of functionally defined stem cells. Utilizing an optimized single-cell bisulfite sequencing protocol, we obtained quantitative DNA methylation measurements of up to 5.7 million CpGs in single hematopoietic cells. In parallel, we developed an analytical strategy (PDclust) to define single-cell DNA methylation states through pairwise comparisons of single-CpG methylation measurements. PDclust revealed that a single-cell epigenetic state can be described by a small (<1%) stochastically sampled fraction of CpGs and that these states are reflective of cell identity and state. Using relationships revealed by PDclust, we derive near complete methylomes for epigenetically distinct subpopulations of hematopoietic cells enriched for functional stem cell content. We present a single-cell methylation protocol and novel analytical method to enable high-resolution reconstruction of regulatory states within rare epigenetically distinct subpopulations of highly purified murine and human hematopoietic stem cells. Pairwise single-CpG-based analysis revealed a high degree of redundancy in single-cell epigenetic states.

Idioma originalEnglish
Páginas (desde-hasta)578-592
Número de páginas15
PublicaciónStem Cell Reports
Volumen11
N.º2
DOI
EstadoPublished - ago. 14 2018
Publicado de forma externa

Nota bibliográfica

Funding Information:
This work was supported by Terry Fox Research Institute Program Projects (grant no. 1021) awarded to M.H. and grant nos. 122869 and 1074 awarded to M.H., A.K., and C.J.E., Canadian Institutes of Health Research (CIHR), Genome Canada and Genome British Columbia (CIHR EP1-120589) awarded to M.H., a Canadian Cancer Society grant generously supported by the Lotte & John Hecht Memorial Foundation (grant no. 703489) to M.H., a CIHR and Canadian Cancer Society Research Institute grant to A.K., a CIHR-National Science and Engineering Research Council of Canada grant (CHRP 413633) to C.E., and a Terry Fox Research Institute New Investigator Award (grant no. 1039) to M.H. K.O. was supported by A Michael Smith Foundation for Health Research Trainee Award (no. 16127). T.H. was supported by a Canada Graduate Scholarship - Master's Award (CGS-M), D.J.H.F.K. by a Vanier Scholarship, and C.A.H. by a CIHR Frederick Banting and Charles Best Doctoral Scholarship. A.K. was supported by the John Auston BC Cancer Foundation Clinical Investigator Award. This research was enabled in part by support provided by WestGrid and Compute Canada (www.computecanada.ca) and Canada Foundation for Innovation (nos. 31343 and 31098). The authors wish to acknowledge Canada's Michael Smith Genome Sciences Center, Vancouver, Canada for computational resources and support and the Stem Cell Assay of the BC Cancer Agency for assistance in obtaining and isolating the cord blood cells used. A full list of other funders of infrastructure and research supporting the services accessed is available at www.bcgsc.ca/about/funding_support.

Funding Information:
This work was supported by Terry Fox Research Institute Program Projects (grant no. 1021 ) awarded to M.H. and grant nos. 122869 and 1074 awarded to M.H., A.K., and C.J.E., Canadian Institutes of Health Research (CIHR), Genome Canada and Genome British Columbia (CIHR EP1- 120589 ) awarded to M.H., a Canadian Cancer Society grant generously supported by the Lotte & John Hecht Memorial Foundation (grant no. 703489 ) to M.H., a CIHR and Canadian Cancer Society Research Institute grant to A.K., a CIHR- National Science and Engineering Research Council of Canada grant ( CHRP 413633 ) to C.E., and a Terry Fox Research Institute New Investigator Award (grant no. 1039 ) to M.H. K.O. was supported by A Michael Smith Foundation for Health Research Trainee Award (no. 16127 ). T.H. was supported by a Canada Graduate Scholarship - Master's Award (CGS-M), D.J.H.F.K. by a Vanier Scholarship, and C.A.H. by a CIHR Frederick Banting and Charles Best Doctoral Scholarship. A.K. was supported by the John Auston BC Cancer Foundation Clinical Investigator Award. This research was enabled in part by support provided by WestGrid and Compute Canada ( www.computecanada.ca ) and Canada Foundation for Innovation (nos. 31343 and 31098 ). The authors wish to acknowledge Canada's Michael Smith Genome Sciences Center, Vancouver, Canada for computational resources and support and the Stem Cell Assay of the BC Cancer Agency for assistance in obtaining and isolating the cord blood cells used. A full list of other funders of infrastructure and research supporting the services accessed is available at www.bcgsc.ca/about/funding_support .

Publisher Copyright:
© 2018 The Authors

ASJC Scopus Subject Areas

  • Biochemistry
  • Genetics
  • Developmental Biology
  • Cell Biology

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't

Huella

Profundice en los temas de investigación de 'High-Resolution Single-Cell DNA Methylation Measurements Reveal Epigenetically Distinct Hematopoietic Stem Cell Subpopulations'. En conjunto forman una huella única.

Citar esto